Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZADH2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | TIGD3 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | ZMYM2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | CBFA2T2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | SEZ6 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | ZNF711 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | GPRIN1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |